SUPRIYA VAIDYA: Open Payments
NPI 1740957778 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 14 payments from 7 companies in 2025. Trend: 2023 $135 · 2024 $434 · 2025 $464
Food & beverage: $369Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $148 |
| AstraZeneca Pharmaceuticals LP | 2 | $120 |
| Adaptive Biotechnologies Corporation | 4 | $84 |
| PFIZER INC. | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Genmab U.S., Inc. | 1 | $22 |
Products named: EPKINLY, clonoSEQ, ADCETRIS, REZUROCK, Fabhalta, CALQUENCE.
Industry payments across CA — which companies pay providers there.
